Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    December 2016
  1. PACKER M, McMurray JJ
    Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.
    Lancet. 2016 Dec 2. pii: S0140-6736(16)30969.
    PubMed     Text format     Abstract available


    November 2016
  2. TEERLINK JR, Felker GM, McMurray JJ, Solomon SD, et al
    Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial.
    Lancet. 2016 Nov 30. pii: S0140-6736(16)32049.
    PubMed     Text format     Abstract available


    September 2016
  3. ARZT M
    Neurostimulation in patients with heart failure and central sleep apnoea.
    Lancet. 2016;388:938-40.
    PubMed     Text format    


    August 2016
  4. PICCINI JP, Fauchier L
    Rhythm control in atrial fibrillation.
    Lancet. 2016;388:829-840.
    PubMed     Text format     Abstract available


  5. VAN GELDER IC, Rienstra M, Crijns HJ, Olshansky B, et al
    Rate control in atrial fibrillation.
    Lancet. 2016;388:818-828.
    PubMed     Text format     Abstract available


    June 2016
  6. POVSIC TJ, Zeiher AM
    IxCELL-DCM: rejuvenation for cardiac regenerative therapy?
    Lancet. 2016;387:2362-3.
    PubMed     Text format    


    April 2016
  7. PATEL AN, Henry TD, Quyyumi AA, Schaer GL, et al
    Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial.
    Lancet. 2016 Apr 5. pii: S0140-6736(16)30137.
    PubMed     Text format     Abstract available


    March 2016
  8. HASENFUSS G, Hayward C, Burkhoff D, Silvestry FE, et al
    A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
    Lancet. 2016;387:1298-304.
    PubMed     Text format     Abstract available


  9. DEL TRIGO M, Bergeron S, Bernier M, Amat-Santos IJ, et al
    Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.
    Lancet. 2016;387:1290-7.
    PubMed     Text format     Abstract available


  10. ROSSIGNOL P, Zannad F
    Left-to-right atrial shunting: new hope for heart failure?
    Lancet. 2016;387:1253-5.
    PubMed     Text format    


  11. DONAHUE JK
    Cardiac gene therapy: a call for basic methods development.
    Lancet. 2016;387:1137-9.
    PubMed     Text format    


  12. GREENBERG B, Butler J, Felker GM, Ponikowski P, et al
    Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.
    Lancet. 2016;387:1178-86.
    PubMed     Text format     Abstract available


    February 2016
  13. BLACHER J, Levy BI, Mourad JJ, Safar ME, et al
    From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century.
    Lancet. 2016 Feb 5. pii: S0140-6736(16)00002.
    PubMed     Text format    


    November 2015
  14. ABRAHAM WT, Stevenson LW, Bourge RC, Lindenfeld JA, et al
    Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.
    Lancet. 2015 Nov 6. pii: S0140-6736(15)00723.
    PubMed     Text format     Abstract available


  15. DAGRES N, Hindricks G
    Pulmonary pressure, telemedicine, and heart failure therapy.
    Lancet. 2015 Nov 6. pii: S0140-6736(15)00808.
    PubMed     Text format    


    October 2015
  16. JOLLY SS, Cairns JA, Yusuf S, Rokoss MJ, et al
    Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
    Lancet. 2015 Oct 12. pii: S0140-6736(15)00448.
    PubMed     Text format     Abstract available


  17. WHITE WB, Kupfer S, Zannad F
    EXAMINE: targeting risk and treatment in diabetes - Authors' reply.
    Lancet. 2015;386:1445.
    PubMed     Text format    


  18. HULSMANN M, Pacher R, Neuhold S
    EXAMINE: targeting risk and treatment in diabetes.
    Lancet. 2015;386:1444-5.
    PubMed     Text format    


  19. DEROSA G, Maffioli P
    EXAMINE: targeting risk and treatment in diabetes.
    Lancet. 2015;386:1443.
    PubMed     Text format    


  20. RICHE DM, Davis C
    EXAMINE: targeting risk and treatment in diabetes.
    Lancet. 2015;386:1443-4.
    PubMed     Text format    


    May 2015
  21. GILBERT RE, Krum H
    Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.
    Lancet. 2015;385:2107-17.
    PubMed     Text format     Abstract available


    April 2015
  22. SHAH R
    beta blockers in patients with heart failure and atrial fibrillation.
    Lancet. 2015;385:1618.
    PubMed     Text format    


  23. KOTECHA D, Altman DG, Manzano L, Flather MD, et al
    beta blockers in patients with heart failure and atrial fibrillation - Authors' reply.
    Lancet. 2015;385:1618-9.
    PubMed     Text format    


  24. PEREZ-CALVO JI, Sanchez-Marteles M, Morales-Rull JL
    beta blockers in patients with heart failure and atrial fibrillation.
    Lancet. 2015;385:1617-8.
    PubMed     Text format    


  25. JEONG HG, Koo DL, Nam H, Kwon HM, et al
    Reversible right heart failure after medullary stroke.
    Lancet. 2015;385:1364.
    PubMed     Text format    


    March 2015
  26. BICH TD, Pham OK, Hai DH, Nguyen NM, et al
    A pregnant woman with acute cardiorespiratory failure: dengue myocarditis.
    Lancet. 2015;385:1260.
    PubMed     Text format    


  27. ZANNAD F, Cannon CP, Cushman WC, Bakris GL, et al
    Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial.
    Lancet. 2015 Mar 9. pii: S0140-6736(14)62225.
    PubMed     Text format     Abstract available


  28. STANDL E, Schnell O
    DPP-4 inhibitors and risk of heart failure EXAMINEd.
    Lancet. 2015 Mar 9. pii: S0140-6736(15)60037.
    PubMed     Text format    


  29. WASHAM JB, Stevens SR, Lokhnygina Y, Halperin JL, et al
    Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tria
    Lancet. 2015 Mar 5. pii: S0140-6736(14)61836.
    PubMed     Text format     Abstract available


    February 2015
  30. CAO TH, Quinn PA, Sandhu JK, Voors AA, et al
    Identification of novel biomarkers in plasma for prediction of treatment response in patients with heart failure.
    Lancet. 2015;385 Suppl 1:S26.
    PubMed     Text format     Abstract available


  31. GREEN D, Ritchie JP, Chrysochou C, Kalra PA, et al
    Revascularisation of renal artery stenosis as a therapy for heart failure: an observational cohort study.
    Lancet. 2015;385 Suppl 1:S11.
    PubMed     Text format     Abstract available


  32. HEALEY JS, Hohnloser SH, Glikson M, Neuzner J, et al
    Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Lancet. 2015 Feb 20. pii: S0140-6736(14)61903.
    PubMed     Text format     Abstract available


    December 2014
  33. MCMURRAY JJ, van Veldhuisen DJ
    beta blockers, atrial fibrillation, and heart failure.
    Lancet. 2014;384:2181-3.
    PubMed     Text format    


    November 2014
  34. BRAUNWALD E
    The war against heart failure: the Lancet lecture.
    Lancet. 2014 Nov 16. pii: S0140-6736(14)61889.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: